DOI:
10.1055/s-00033101
Neurology International Open
LinksClose Window
References
Howard Jr. JF, Barohn RJ, Cutter GR. et al.
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.
Muscle Nerve 2013;
48: 76-84
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.